Who are Nuelle's investors?

Nuelle's investors include Ruvento Ventures Pte Ltd., Windham Capital Partners.

How much funding has Nuelle raised?

Nuelle has disclosed $22.6M raised across 2 rounds.

Where is Nuelle headquartered?

Nuelle is headquartered in Mountain View, US.

Nuelle

Mountain View, US · Founded 2013 · 2 known investors

Aytu BioPharma is a pharmaceutical company developing treatments for complex central nervous system (CNS) conditions, including major depressive disorder (MDD) and ADHD. It focuses on delivering these therapies to patients affected by psychiatric conditions.

Biotech Healthtech

Founders & leadership

Davis YangNamed on SEC filing

Joshua MakowerNamed on SEC filing

John NehraNamed on SEC filing

Stefano CurtiNamed on SEC filing

Yi LiNamed on SEC filing

Ryan DrantNamed on SEC filing

Investors · 2

Ruvento Ventures Pte Ltd.Singapore · $100K – $500Kvia Soltan Bichiev · inferred

Windham Capital PartnersNew York · $1M – $5M

Reported raises · per SEC filings

Form D private placements

$22.6M disclosed across 2 rounds · 2014–2015

▶$7.1MraisedApr 2015 · 4 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Sylvia LagnadoDirector
Joshua MakowerExecutive Officer, Director
Ryan DrantDirector
Davis YangDirector

Offering amount: $7.5M
Amount sold: $7.1M
Minimum investment: $1
First sale: Apr 2015
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$15.5MraisedJul 2014 · 28 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Davis YangDirector
Joshua MakowerExecutive Officer, Director
John NehraDirector
Stefano CurtiExecutive Officer, Director
Yi LiDirector
Ryan DrantDirector

Offering amount: $15.5M
Amount sold: $15.5M
Minimum investment: $1
First sale: Jan 2014
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Fence raises $20m to modernise asset-backed financefintech.global · Apr 2026

Axis raises $5 million in round led by Galaxy Ventures to launch onchain yield protocol for USD, bitcoin and gold | The Blocktheblock.co · Dec 2025

Startup raises $7.5M for female sexual arousal tech | Fierce Biotechfiercebiotech.com · Apr 2015

Frequently asked questions

What does Nuelle do?: Aytu BioPharma is a pharmaceutical company developing treatments for complex central nervous system (CNS) conditions, including major depressive disorder (MDD) and ADHD. It focuses on delivering these therapies to patients affected by psychiatric conditions.
Who are Nuelle's investors?: Nuelle's investors include Ruvento Ventures Pte Ltd., Windham Capital Partners.
How much funding has Nuelle raised?: Nuelle has disclosed $22.6M raised across 2 rounds.
Where is Nuelle headquartered?: Nuelle is headquartered in Mountain View, US.